Home monitoring of breathing rate in people with chronic obstructive pulmonary disease: observational study of feasibility, acceptability, and change after exacerbation

Autor: Rubio N, Parker RA, Drost EM, Pinnock H, Weir CJ, Hanley J, Mantoani LC, McKinstry B, Rabinovich RA

Publikováno v: International Journal of COPD, Vol Volume 12, Pp 1221-1231 (2017)

Noah Rubio,1 Richard A Parker,2 Ellen M Drost,1 Hilary Pinnock,3,4 Christopher J Weir,2 Janet Hanley,5 Leandro C Mantoani,1 William MacNee,1 Brian McKinstry,2,4 Roberto A Rabinovich1 1Edinburgh Lung and the Environment Group Initiative (ELEGI) Colt L

Externí odkaz: https://doaj.org/article/c4d7c31f570a4dd3904169a08b8978ed

Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART).:a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis

Autor: Connick, P, De Angelis, F, Parker, Ra, Plantone, D, Doshi, A, John, N, Stutters, J, Macmanus, D, Prados Carrasco, F, Barkhof, F, Ourselin, S, Braisher, M, Ross, M, Cranswick, G, Pavitt, Sh, Giovannoni, G, Gandini Wheeler-Kingshott CA, Hawkins, C, Sharrack, B, Bastow, R, Weir, Cj, Stallard, N, Chandran, S, Chataway, J, UK Multiple Sclerosis Society Clinical Trials, Network.

Publikováno v: Connick, P, De Angelis, F, Parker, R, Plantone, D, Doshi, A, John, N, Stutters, J, MacManus, D, Prados Carrasco, F, Barkhof, F, Ourselin, S, Braisher, M, Ross, M & Cranswick, G & Weir, C 2018, ' Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART). a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis ', BMJ Open . https://doi.org/10.1136/bmjopen-2018-021944
Connick, P, De Angelis, F, Parker, R A, Plantone, D, Doshi, A, John, N, Stutters, J, Macmanus, D, Prados Carrasco, F, Barkhof, F, Ourselin, S, Braisher, M, Ross, M, Cranswick, G, Pavitt, S H, Giovannoni, G, Gandini Wheeler-Kingshott, C A, Hawkins, C, Sharrack, B, Bastow, R, Weir, C J, Stallard, N, Chandran, S & Chataway, J 2018, ' Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART) : A multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis ', BMJ Open, vol. 8, no. 8, e021944 . https://doi.org/10.1136/bmjopen-2018-021944
BMJ Open, 8(8):e021944. BMJ Publishing Group
BMJ Open

IntroductionThe major unmet need in multiple sclerosis (MS) is for neuroprotective therapies that can slow (or ideally stop) the rate of disease progression. The UK MS Society Clinical Trials Network (CTN) was initiated in 2007 with the purpose of de

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66923089bdc106d1eba9998777926e8f
https://hdl.handle.net/20.500.11820/c9a0ef03-ec4e-4816-90f6-cbb523836bff

Spinal cord area is a stronger predictor of physical disability than brain volume in secondary progressive Multiple Sclerosis

Autor: De Angelis, F, Stutters, J, Eshaghi, A, Garcia, A, Prados, F, Plantone, D, Doshi, A, John, Na, Calvi, A, Macmanus, D, Ourselin, S, Pavitt, S, Giovannoni, G, Parker, R, Weir, Cj, Stallard, N, Hawkins, Cp, Sharrack, B, Connick, P, Chandran, S, Wheeler-Kingshott, Cag, Barkhof, F, Chataway, J

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1820::02447a75fab8bb6f393b7af938acb12a
http://hdl.handle.net/11365/1153477

Embracing model-based designs for dose-finding trials

Autor: Love, SB, Brown, S, Weir, CJ, Harbron, C, Yap, C, Gaschler-Markefski, B, Matcham, J

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1064::6eb65bec94045bcb592fb6ff43672487
https://ora.ox.ac.uk/objects/uuid:fef8e9b9-9d5f-4c06-aa9e-f25b671063ca

Effect of carvedilol in patients with or without renal impairment after myocardial infarction: analysis of the carvedilol post-infarct survival control in left ventricular dysfunction (CAPRICORN) study

Autor: Castagno, Davide, Jhund, Ps, Weir, Cj, Colucci, Ws, Sendon, Jll, Remme, Wj, Sharpe, N, Ford, I, Dargie, Hj, Mcmurray, J. J. V.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______970::251207adf9b81e99b919d5d59973ef75
http://hdl.handle.net/2318/134696